Management of Respiratory Symptoms in Individuals Diagnosed with Advanced-Stage Lung Cancer
Abstract
Introduction: Lung cancer is the second most frequent disease worldwide and the major cause of cancer deaths. Most lung cancer patients are already in the final stages of the disease by the time symptoms appear. Multiple studies have found that lung cancer patients experience significant symptom distress, particularly respiratory problems. Multiple symptoms can cause individuals severe discomfort and lower their quality of life and ability to function. Thus, effective respiratory treatment is crucial. Understanding the best management strategies in this field is essential for advancing knowledge and improving lung cancer patients' quality of life.
Main Text: The respiratory symptoms reported in people with lung cancer can arise from various factors, including airway obstruction, involvement of the lung parenchyma and pleura, abnormalities in the vascular and neuromuscular systems, and side effects of the treatments delivered. The most commonly evaluated and documented symptoms included cough, dyspnea, hemoptysis, stridor, and pain in the chest. The optimal utilization of pharmacological and non-pharmacological interventions is crucial in reducing the burden of symptoms.
Conclusion: Treating distressing respiratory symptoms in lung cancer is a complicated process. While significant advancements have been achieved in comprehending the symptoms linked to lung cancer, additional headway is required to reduce the morbidity associated with unmanaged symptoms. Specifically, there is a need for more research to enhance the management of symptoms in lung cancer patients to improve their quality of life and outcome.
Keywords
References
Barisione, E., Genova, C., Grosso, M., Pasquali, M., Blanco, A., Felletti, R., & Salio, M. (2017). Palliative treatment of life-threatening hemoptysis with silicone stent insertion in advanced lung cancer. Monaldi Archives for Chest Disease, 87(1), 65–69. https://doi.org/10.4081/monaldi.2017.781
Barnes, H., Mcdonald, J., Smallwood, N., & Manser, R. (2014). Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database of Systematic Reviews, 2014(3). https://doi.org/10.1002/14651858.CD011008
DiBardino, D. M., Lanfranco, A. R., & Haas, A. R. (2016). Bronchoscopic cryotherapy: Clinical applications of the cryoprobe, cryospray, and cryoadhesion. Annals of the American Thoracic Society, 13(8), 1405–1415. https://doi.org/10.1513/AnnalsATS.201601-062FR
Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I. (2018). Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Annals of Oncology, 29(July), iv166–iv191. https://doi.org/10.1093/annonc/mdy152
Folch, E., & Keyes, C. (2018). Airway stents. Annals of Cardiothoracic Surgery, 7(2), 273–283. https://doi.org/10.21037/acs.2018.03.08
Gershman, E., Guthrie, R., Swiatek, K., & Shojaee, S. (2019). Management of hemoptysis in patients with lung cancer. Annals of Translational Medicine, 7(15), 358–358. https://doi.org/10.21037/atm.2019.04.91
Harle, A., Molassiotis, A., Buffin, O., Burnham, J., Smith, J., Yorke, J., & Blackhall, F. H. (2020). A cross sectional study to determine the prevalence of cough and its impact in patients with lung cancer: A patient unmet need. BMC Cancer, 20(1), 1–8. https://doi.org/10.1186/s12885-019-6451-1
Harle, A. S. M., Blackhall, F. H., Smith, J. A., & Molassiotis, A. (2012). Understanding cough and its management in lung cancer. Current Opinion in Supportive and Palliative Care, 6(2), 153–162. https://doi.org/10.1097/SPC.0b013e328352b6a5
Hochberg, U., Elgueta, M. F., & Perez, J. (2017). Interventional analgesic management of lung cancer pain. Frontiers in Oncology, 7(FEB), 1–10. https://doi.org/10.3389/fonc.2017.00017
Howell, D. (2021). Enabling patients in effective self-management of breathlessness in lung cancer: The neglected pillar of personalized medicine. Lung Cancer Management, 10(4). https://doi.org/10.2217/lmt-2020-0017
Howell, D., Mayer, D. K., Fielding, R., Eicher, M., Verdonck-De Leeuw, I. M., Johansen, C., Soto-Perez-De-Celis, E., Foster, C., Chan, R., Alfano, C. M., Hudson, S. V., Jefford, M., Lam, W. W. T., Loerzel, V., Pravettoni, G., Rammant, E., Schapira, L., Stein, K. D., & Koczwara, B. (2021). Management of cancer and health after the clinic visit: A call to action for self-management in cancer care. Journal of the National Cancer Institute, 113(5), 523–531. https://doi.org/10.1093/jnci/djaa083
Kloke, M., & Cherny, N. (2015). Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines. Annals of Oncology, 26(July), v169–v173. https://doi.org/10.1093/annonc/mdv306
Lou, V. W. Q., Chen, E. J., Jian, H., Zhou, Z., Zhu, J., Li, G., & He, Y. (2017). Respiratory Symptoms, Sleep, and Quality of Life in Patients With Advanced Lung Cancer. Journal of Pain and Symptom Management, 53(2), 250-256.e1. https://doi.org/10.1016/j.jpainsymman.2016.09.006
McCannon, J., & Temel, J. (2012). Comprehensive management of respiratory symptoms in patients with advanced lung cancer. Journal of Supportive Oncology, 10(1), 1–8. https://doi.org/10.1016/j.suponc.2011.07.002
Molassiotis, A., Smith, J. A., Mazzone, P., Blackhall, F., Irwin, R. S., Adams, T. M., Altman, K. W., Barker, A. F., Birring, S. S., Blackhall, F., Bolser, D. C., Boulet, L.-P., Braman, S. S., Brightling, C., Callahan-Lyon, P., Canning, B. J., Chang, A. B., Cowley, T., Davenport, P., … Weir, K. (2017). Symptomatic Treatment of Cough Among Adult Patients With Lung Cancer. Chest, 151(4), 861–874. https://doi.org/10.1016/j.chest.2016.12.028
Nurwidya, F., Syahruddin, E., & Yunus, F. (2016). Pain management in lung cancer. Advances in Respiratory Medicine, 84(3), 331–336. https://doi.org/10.5603/ARM.2016.0043
Oberg, C., Folch, E., & Santacruz, J. F. (2018). Management of malignant airway obstruction. AME Medical Journal, 3, 115–115. https://doi.org/10.21037/amj.2018.11.06
Peeters-Asdourian, C., Massard, G., Rana, P. H., Van Houtte, P., White, A. P., Grigoriu, B., Lossignol, D., Almalki, M., Alexiou, J., Engelholm, J. L., & Sculier, J. P. (2017). Pain control in thoracic oncology. European Respiratory Journal, 50(3), 1–17. https://doi.org/10.1183/13993003.00611-2017
Radchenko, C., Alraiyes, A. H., & Shojaee, S. (2017). A systematic approach to the management of massive hemoptysis. Journal of Thoracic Disease, 9(5), S1069–S1086. https://doi.org/10.21037/jtd.2017.06.41
Seaman, J. C., & Musani, A. I. (2013). Endobronchial Ablative Therapies. Clinics in Chest Medicine, 34(3), 417–425. https://doi.org/10.1016/j.ccm.2013.04.006
Simon, S. T., Higginson, I. J., Booth, S., Harding, R., Weingärtner, V., & Bausewein, C. (2016). Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database of Systematic Reviews, 2016(10). https://doi.org/10.1002/14651858.CD007354.pub3
Skowronek, J. (2015). Brachytherapy in the treatment of lung cancer - a valuable solution. Journal of Contemporary Brachytherapy, 7(4), 297–311. https://doi.org/10.5114/jcb.2015.54038
Stevic, R., & Milenkovic, B. (2016). Tracheobronchial tumors. Journal of Thoracic Disease, 8(11), 3401–3413. https://doi.org/10.21037/jtd.2016.11.24
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Wand, O., Guber, E., Guber, A., Epstein Shochet, G., Israeli-Shani, L., & Shitrit, D. (2018). Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial. Chest, 154(6), 1379–1384. https://doi.org/10.1016/j.chest.2018.09.026
Wheless, L., Brashears, J., & Alberg, A. J. (2013). Epidemiology of lung cancer. Lung Cancer Imaging, 1–15. https://doi.org/10.1007/978-1-60761-620-7_1
Yasuda, S., Sugano, K., Matsuda, Y., Kako, J., Takagi, Y., Watanabe, H., Kasahara, Y., Goya, S., Kohara, H., Mori, M., Nakayama, T., & Yamaguchi, T. (2023). Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer. Japanese Journal of Clinical Oncology, 53(4), 327–334. https://doi.org/10.1093/jjco/hyac206
Yazıcıoğlu, A., Yekeler, E., Yazıcı, Ü., Aydın, E., Taştepe, İ., & Karaoğlanoğlu, N. (2016). Management of massive hemoptysis: Analyses of 58 patients. Turkish Thoracic Journal, 17(4), 148–152. https://doi.org/10.5152/TurkThoracJ.2016.002
Zhang, B., Li, X., Ma, Z., Zhang, S., Song, X., Gao, H., Gong, L., Hu, Y., Wang, M., Jiang, D., Zhang, C., Yuan, X., Cao, B., Zhang, P., Nie, L., Zhang, Y., Chen, X., Han, L., Wei, W., & Shi, Y. (2022). Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross-sectional study. Thoracic Cancer, 13(11), 1684–1690. https://doi.org/10.1111/1759-7714.14444
Zheng, Z., Zhuang, Z., Yang, M., Luo, J., Zhang, W., Yan, Z., & Wang, X. (2021). Bronchial artery embolization for hemoptysis: A systematic review and meta-analysis. Journal of Interventional Medicine, 4(4), 172–180. https://doi.org/10.1016/j.jimed.2021.08.003
DOI: 10.24815/jks.v24i2.37787
Refbacks
- There are currently no refbacks.